As a member of the Chugai-Roche Group, Chugai Pharma USA LLC (CPUSA), founded in 1995 in San Diego, CA and currently based in Bedminster, NJ, is committed to the timely development and commercialization of safe and effective drugs for the North American market place. For more than 70 years our parent company, Chugai Pharmaceutical Co. Ltd., has provided high quality, safe and effective drugs to the Japanese & global market place, a heritage that will be continued in North America by CPUSA. As a result of our alliance with F. Hoffmann-La Roche Ltd. in 2002, CPUSA enjoys the resources of a large global conglomerate while preserving the focus and agility of a small local company. CPUSA maintains the same therapeutic focuses as our parent, currently working mainly in the areas of treatments for cardiovascular disease, cancer, metabolic disease and diseases involving inflammation. We are a company of collaborative, committed, talented and experienced people with an unwavering dedication to quality and the highest environmental and ethical standards. We all take great pride in bringing new medicines to market for the benefit of those in need.